Towards Healthcare

Clinical Nutrition Companies and Corporate Milestones

Date : 07 November 2025

Discover the Key Players Driving the Clinical Nutrition Market

Fueling Health: An Overview of the Clinical Nutrition Market

The clinical nutrition market is increasingly centered on personalized and targeted nutrition, microbiome research, women’s health, and surgical and critical care nutrition. Alongside this, there is a growing emphasis on producing healthy and sustainable food products while making nutrition more accessible to a broader population. Initiatives such as those by the American Journal of Clinical Nutrition bring together cutting-edge research from diverse fields to foster collaboration, including studies on nutritional considerations amid emerging obesity medications. Similarly, the European Society for Clinical Nutrition and Metabolism (ESPEN) has issued scientific guidelines on clinical nutrition in surgery and focused research on areas such as nutrition and hydration in dementia, as well as nutrition care for cystic fibrosis, highlighting the sector’s breadth and depth.

Market Growth

The global clinical nutrition market size is estimated at US$ 78.15 billion in 2025, increased to US$ 84.48 billion in 2026, and is expected to reach around US$ 170.12 billion by 2035. The market is growing at a CAGR of 8.1% between 2026 and 2035.

Companies Overview

Abbott Laboratories

Corporate Information: Headquarters: Abbott Park, Illinois, U.S.  | Year Founded: 1888

Business Overview

Abbott Laboratories is a diversified global healthcare company engaged in the discovery, development, manufacture, and sale of nutritional products, diagnostics, medical devices, and branded generic pharmaceuticals. Within the nutrition category, Abbott Nutrition offers science-based nutritional solutions spanning pediatric, adult, and therapeutic/disease-specific segments.

Business Segments / Divisions

Key reportable segments include:

  • Nutrition (adult, pediatric, specialty/diseasespecific)
  • Diagnostics (core lab, molecular, pointofcare)
  • Medical Devices (cardiovascular, diabetes care, neuromodulation)
  • Branded/Established Pharmaceuticals (primarily emerging markets)

Geographic Presence

Abbott operates in over 160 countries globally, reaching a very broad market footprint across the Americas, Europe, AsiaPacific, the Middle East & Africa, and Latin America. Its nutrition business targets both developed and emerging markets, with tailored products for local needs and investments in manufacturing and the supply chain to support global reach.

Key Offerings (Pertaining to Clinical Nutrition)

  • Ensure®: Adult complete nutrition & supplemental shakes for general health, aging populations, and post-acute recovery.
  • Glucerna®: Diseasespecific nutritional solutions for people with diabetes, including shakes and feed formulas.
  • Similac®, PediaSure®, etc.: Pediatric and infant nutrition formulas for growth, special needs, and clinical settings.
  • Specialty feeds and therapeutic formulas for metabolic disorders, malnutrition support, and hospital/home care nutrition.

SWOT Analysis

  • Strengths
    • Diversified product portfolio across nutrition, diagnostics, devices, and pharmaceuticals, providing multiple revenue streams.
    • Strong global presence, enabling access to developed and emerging markets.
    • Established leadership in adult and pediatric nutrition science and trusted brand names (Ensure, Similac, Glucerna).
  • Weaknesses
    • Heavy regulatory and reimbursement dependencies in the clinical nutrition market, which may slow product adoption.
    • Exposure to currency and supplychain risks due to broad global operations and manufacturing footprint. (Implied via global revenue breakdowns)
  • Opportunities
    • Growth in home-based nutrition therapies, telehealth integration, and digital health monitoring in clinical nutrition.
    • Rising demand in emerging regions (AsiaPacific, Latin America) for disease-specific, geriatric, and pediatric nutrition products.
    • Innovation in plant-based, clean-label, and sustainable nutrition products aligned with global wellness trends.
  • Threats
    • Intense competition from other major nutrition companies and regional/low-cost players.
    • Changes in healthcare reimbursement, regulatory scrutiny, or supplychain disruptions that could impact cost or availability.
    • Shifts in consumer or provider preferences and potential substitution by alternative treatments or therapies.

Nestlé Health Science

Corporate Information:  Headquarters: Epalinges (near Lausanne), Switzerland.  |  Year Founded: 2011.

Business Overview

Nestlé Health Science is a globally-managed unit within the Nestlé S.A. Group, dedicated to advancing the therapeutic role of nutrition. It offers science-based solutions for both medical/clinical nutrition and consumer-oriented nutritional health, aiming to support patients across their health journey, from disease-specific interventions to active lifestyle support.

Business Segments / Divisions

NHSc operates substantially in two broad divisions:

  • Medical Nutrition (also called clinical nutrition) – specialized products for patients with disease states, critical care needs, pediatrics, gastrointestinal, metabolic, oncology, and other conditions.
  • Consumer/Active-Lifestyle Nutrition – nutritional supplements, vitamins, minerals, and wellness-oriented products available via retail and consumer channels.
  • In addition, NHSc pursues innovation in “Novel Therapeutic Nutrition” and is increasingly bridging nutritional therapies and clinical outcomes.

Geographic Presence

NHSc has a presence in over 140 countries. It maintains globally-managed operations whilst benefiting from the Nestlé Group’s broad infrastructure and applies region-specific solutions through its Product Technology Centers in Europe, China, and the U.S.

Key Offerings (Pertaining to Clinical/Medical Nutrition)

  • Nutrition solutions for adult, pediatric, and geriatric populations with specific conditions: e.g., gastrointestinal disease, metabolic disorders, critical care/surgery, oncology, food allergies.
  • Brands and products (clinical nutrition) include specialized enteral feeding formulas, disease-specific nutrition, tube-feeding, and hospital nutrition solutions.
  • Portfolio also supports nutrition for active lifestyles and wellness (though this portion is more consumer-oriented), thereby linking clinical nutrition to broader health trends.

SWOT Analysis

  • Strengths
    • Strong backing of the Nestlé Group, leveraging global scale, R&D infrastructure, and brand credibility.
    • Broad portfolio covering both medical and consumer nutrition, enabling reach into diverse patient and consumer segments.
    • Global presence and access to emerging markets, plus partnerships/ acquisitions boosting innovation in nutrition therapies (e.g., microbiome focus).
  • Weaknesses
    • Medical nutrition is subject to regulatory, reimbursement, and clinical evidence requirements, which may slow adoption.
    • Integration of consumer and clinical nutrition businesses may complicate focus; balancing wellness vs therapy segments can create strategic tension.
  • Opportunities
    • Growing demand for disease-specific nutrition (e.g., oncology, metabolic, GI disorders) and the shift toward home-based care/interventions.
    • Expansion in emerging markets where clinical nutrition penetration is lower and growth potential is high.
    • Innovations in personalized nutrition, digital health/monitoring, microbiome-based nutrition therapies, and sustainable formulations.
  • Threats
    • Intense competition from specialized nutrition companies, generic entrants, and low-cost players in key markets.
    • Healthcare reimbursement changes, cost pressures, and regulatory scrutiny around nutrition claims.
    • Supply-chain disruptions, raw material cost volatility (especially in specialized nutrition formulations), and currency risks from global operations.

Recent News

On November 3, 2025, Nestlé partnered with leading universities to accelerate open innovation in nutrition and health, focusing on women’s health, healthy longevity, and weight management. The initiative reinforced Nestlé’s commitment to advancing nutritional solutions aligned with its emerging growth platforms.

Major Companies and their Key Offerings

Danone S.A. (Nutricia)

Key Offering:

Clinical nutrition solutions such as Fortisip, Nutrison, and other enteral feeding formulas designed for both adult and pediatric applications.

Fresenius Kabi AG

Key Offering:

Enteral and parenteral nutrition products for hospitals and home care, featuring advanced formulations for oncology and intensive care patients.

Baxter International Inc.

Key Offering:

Specialized parenteral nutrition therapies, including amino acid and lipid solutions for critically ill, surgical, and long-term care patients.

B. Braun Melsungen AG

Key Offering:

A wide range of clinical nutrition products and infusion therapies catering to both hospital and home-care patients for enteral and parenteral feeding.

Ajinomoto Co., Inc.

Key Offering:

Amino-acid-based nutrition molecules and precision nutrient blends developed for medical nutrition, focusing on metabolic and critical-care segments.

Perrigo Company plc

Key Offering:

Contract-manufactured and specialty clinical nutrition products, including B2B formulations and shelf-stable feeds.

Kate Farms Inc.

Key Offering:

Plant-based, organic clinical nutrition formulations for adults and tube-fed patients, aligning with clean-label and alternative nutrition trends.

Meiji Holdings Co., Ltd.

Key Offering:

Geriatric and pediatric enteral nutrition products in Asia, supporting the region’s growing demand for clinical nutrition solutions.

Otsuka Pharmaceutical Co., Ltd.

Key Offering:

Enteral and medical nutrition products designed for chronic disease management and specialized adult nutrition markets in Asia.

Vitaflo International Ltd.

Key Offering:

Clinical nutrition solutions tailored for metabolic disorders such as PKU and MSUD, serving both adult and pediatric patients.

Medtrition Inc.

Key Offering:

Disease-specific medical nutrition products for adults, primarily catering to hospital and home-care markets across North America.

Aenova Group

Key Offering:

Contract manufacturing of clinical nutrition and medical-food formulations for global nutrition brands.

Archer-Daniels-Midland Company (ADM)

Key Offering:

Specialty ingredients, nutrient-rich blends, and bioactive compounds that support the formulation and manufacturing of clinical nutrition products.

Clinical Nutrition Market Value Chain Analysis

R&D

The R&D process in clinical nutrition involves multi-stage approaches such as idea generation, market research, concept development, formulation, prototyping, testing, regulatory review, business analysis, scale-up, and commercialization.

Key Players: Nestlé Health Science, Abbott Laboratories, Danone Nutricia, Fresenius Kabi, B. Braun Melsungen AG, Otsuka Pharmaceutical Factory, Baxter International.

Distribution to Hospitals, Pharmacies

The primary distribution channels, such as hospitals and pharmacies, are expanding due to the shift toward home-based care, automation, digital transformation, emphasis on cold chain logistics, and the rapid rise of e-commerce.

Key Players: Nestlé Health Science, Abbott Laboratories, Danone Nutricia, Fresenius Kabi.

Patient Support and Services

Key services such as personalized nutrition, weight management, and others are primarily powered by AI, big data, telehealth, remote monitoring, digital tools for professionals, and food tech innovations.

Key Players: Ajinomoto Co., Inc., Medtrition Inc., Kate Farms, Nestlé Health Science, Abbott Laboratories, Danone Nutricia.

Recent Developments in the Market

  • In October 2024, Fresenius Kabi continued its partnership with researchers to optimize patient care, particularly for acutely and chronically ill patients, and support research in medical nutrition.
  • In September 2025, Baxter International announced its honor as the first manufacturer to achieve the Gold Resiliency Badge for nutrition solutions, IV solutions, and premix drugs from the Healthcare Industry Resilience Collaborative (HIRC). 

Exclusive Analysis

The global clinical nutrition market is undergoing a paradigm shift, underpinned by the escalating incidence of chronic and metabolic diseases, an aging population base, and the increasing recognition of nutrition as a therapeutic adjunct in clinical care pathways. The industry is progressively aligning with precision medicine principles, emphasizing patient-specific formulations, microbiome modulation, and targeted nutritional interventions that enhance clinical outcomes. These developments, coupled with technological integration, such as AI-assisted nutrition planning and remote monitoring, are redefining the boundaries of traditional nutritional therapy and establishing new standards for personalized medical care.

Market expansion is being further catalyzed by macroeconomic and policy drivers, including the proliferation of home healthcare services, regulatory endorsement for specialized nutritional products, and the emergence of digital health ecosystems. Multinational corporations are actively pursuing mergers, acquisitions, and R&D collaborations to strengthen their therapeutic portfolios across oncology, critical care, pediatrics, and metabolic health. The incorporation of plant-based, clean-label, and sustainable ingredients has not only broadened consumer acceptance but also provided new revenue streams, particularly in high-growth regions such as Asia-Pacific and Latin America, where healthcare modernization and middle-class expansion are converging.

From an investment perspective, the clinical nutrition domain represents a high-margin, defensible growth segment within the broader healthcare continuum. Increasing penetration of advanced enteral and parenteral nutrition, supported by innovations in bioavailability, formulation science, and digital adherence tracking, creates opportunities for both incumbents and emerging players. As payers and providers shift toward value-based care and preventive health models, the market’s potential lies in its capacity to integrate nutritional science with data-driven clinical decision-making, positioning clinical nutrition as a cornerstone of future precision healthcare systems.

Partner with our experts to explore the clinical nutrition market at sales@towardshealthcare.com